Drug Trial Radar · NCT07641504
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain
Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Aug 12, 2026
Primary completion
Apr 2027
Study completion Apr 2027
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Jun 11, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to test the safety and efficacy of study drug for the treatment of chronic low back pain (CLBP). This trial is part of the chronic pain master protocol H0P-MC-CPMP (NCT05986292), which is a protocol to accelerate the development of new treatments for chronic pain.
Conditions
- Chronic Pain
- Low Back Pain
Interventions
LY4065967Drug
Administered orally.
PlaceboDrug
Administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in Average Pain Intensity as Measured by the Numeric Rating Scale (NRS)Time frame: Baseline, Week 8
Locations
36 sites in 2 countries. Site status is shown where the registry gives one.
Central Research Associates
Birmingham, Alabama · Recruiting
Synexus Clinical Research US, Inc.
Phoenix, Arizona · Recruiting
Arizona Research Center
Phoenix, Arizona · Recruiting
Desert Oasis Healthcare Medical Group
Palm Springs, California · Recruiting
Artemis Institute for Clinical Research
Riverside, California · Recruiting
Artemis Institute for Clinical Research
San Diego, California · Recruiting
CMR of Greater New Haven
Hamden, Connecticut · Recruiting
Bradenton Research Center, Inc.
Bradenton, Florida · Recruiting
Accel Research Sites - DeLand Clinical Research Unit
DeLand, Florida · Recruiting
K2 MEDICAL Research THE VILLAGES
Lady Lake, Florida · Recruiting
K2 Medical Research ORLANDO
Maitland, Florida · Recruiting
Merritt Island Medical Research, LLC
Merritt Island, Florida · Recruiting
Suncoast Research Group
Miami, Florida · Recruiting
New Horizon Research Center
Miami, Florida · Recruiting
Suncoast Clinical Research, Inc.
New Port Richey, Florida · Recruiting
Renstar Medical Research
Ocala, Florida · Recruiting
Precision Clinical Research
Sunrise, Florida · Recruiting
Charter Research - Lady Lake
The Villages, Florida · Recruiting
Conquest Research
Winter Park, Florida · Recruiting
North Georgia Clinical Research
Woodstock, Georgia · Recruiting
Northwestern University
Chicago, Illinois · Recruiting
DelRicht Research
New Orleans, Louisiana · Recruiting
Lucida Clinical Trials
New Bedford, Massachusetts · Recruiting
MedVadis Research Corporation
Waltham, Massachusetts · Recruiting
Great Lakes Research Group, Inc.
Bay City, Michigan · Recruiting
StudyMetrix Research
City of Saint Peters, Missouri · Recruiting
Clinvest Research LLC
Springfield, Missouri · Recruiting
Rochester Clinical Research, LLC
Rochester, New York · Not yet recruiting
Lillestol Research
Fargo, North Dakota · Recruiting
META Medical Research Institute
Dayton, Ohio · Recruiting
DelRicht Research
Tulsa, Oklahoma · Recruiting
Altoona Center For Clinical Research
Duncansville, Pennsylvania · Recruiting
FutureSearch Trials of Neurology
Austin, Texas · Recruiting
Northwest Clinical Research Center
Bellevue, Washington · Recruiting
Rainier Clinical Research Center
Renton, Washington · Recruiting
Ponce Medical School Foundation Inc.
Ponce, Puerto Rico · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.